(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 13.47% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Biote's revenue in 2024 is $187,321,000.On average, 5 Wall Street analysts forecast BTMD's revenue for 2024 to be $12,532,857,633, with the lowest BTMD revenue forecast at $12,419,703,096, and the highest BTMD revenue forecast at $12,655,441,716. On average, 5 Wall Street analysts forecast BTMD's revenue for 2025 to be $14,482,788,241, with the lowest BTMD revenue forecast at $13,953,244,857, and the highest BTMD revenue forecast at $15,447,083,271.
In 2026, BTMD is forecast to generate $17,250,483,716 in revenue, with the lowest revenue forecast at $15,827,987,252 and the highest revenue forecast at $18,672,980,179.